Evonile Pharma Board Clears ₹900 Crore Rights Issue to Fund Strategic Growth
Evonile Pharma board approves the Letter of Offer and payment schedule for its ₹900 crore rights issue, representing 21.4% of its current market capitalization.
Wednesday, 4 November 2026
NSE & BSE filings, as they land
ALFA News
Straight from the exchange filing